CSIMarket
 
Medidata Solutions Inc   (NASDAQ: MDSO)
    Sector  Technology    Industry Software & Programming
   Industry Software & Programming
   Sector  Technology
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 62
 Employees 1,680
 Revenues (TTM) (Millions $) 685
 Net Income (TTM) (Millions $) 44
 Cash Flow (TTM) (Millions $) 34
 Capital Exp. (TTM) (Millions $) 54

Business Description


Medidata Solutions Inc. is a software and technology company that provides cloud-based solutions for clinical research and development in the pharmaceutical, biotech, and medical device industries. The company was founded in 1999 by Glen de Vries and Tarek Sherif and is headquartered in New York City, with additional offices in Europe, Asia, and South America.

Medidata provides a range of products and services to its clients for clinical trial management, data capture and management, patient engagement, and analytics. Their platform, known as the Medidata Clinical Cloud, is an end-to-end solution that covers the entire clinical trial process from protocol design to regulatory submission. The Cloud includes various applications, such as Medidata Rave EDC, Medidata Balance, Medidata Edge, Medidata Sensor Cloud and more.

One of the company's core products is Medidata Rave, an electronic data capture (EDC) system that allows researchers to capture, store, and analyze clinical trial data. Another key offering is the Medidata Balance platform, which is an advanced randomization and trial supply management system. The company also offers Medidata Edge, a comprehensive platform that provides trial management and oversight, monitoring and data review, and centralized monitoring and site performance metrics.

Medidata Solutions Inc. has gained significant recognition within the industry for its innovative technology and solutions. The company has won numerous awards for its services and products, including the 2019 Scrip Awards for eBest Clinical Trial Technology Solutione and the 2019 Clinical Informatics News Best Practices Award for eBest AI/ Machine Learning Solution.e They were also named the 2020 ISO Quality Management System Standard.

Medidata Solutions Inc. has a broad customer base, including pharmaceutical companies, biotech companies, contract research organizations (CROs), and academic medical centers. The company has partnered with several leading organizations in the industry, including Merck, Pfizer, and Bristol Myers Squibb, among others. Additionally, the company has significant investments in data privacy and security to comply with regulations governing the utilization of clinical data.

Overall, Medidata Solutions Inc. is a leading provider of innovative cloud-based solutions for clinical research and development. Their technology has revolutionized the clinical trial industry by providing solutions that assist with clinical trial design, patient engagement, data management, and analysis, resulting in greater efficiency, reliability, and accuracy in clinical trials.


   Company Address: 350 Hudson Street, 9th Floor New York 10014 NY
   Company Phone Number: 918-1800   Stock Exchange / Ticker: NASDAQ MDSO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
VEEV        13.47% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.24
Working Capital Ratio 2.8
Leverage Ratio (MRQ) 0.39
Total Debt to Equity 0.13
Interest Coverage (TTM) 13.69
Debt Coverage (TTM) 1.07

Per Share Current
Earnings (TTM) 0.71 $
Revenues (TTM) 10.98 $
Cash Flow (TTM) 0.54 $
Cash 3.3 $
Book Value 10.59 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 407,474
Net Income per Employee (TTM) 26,217
Receivable Turnover Ratio (TTM) 3.86
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.72

Profitability Ratios Current
Gross Margin (MRQ) 72.51 %
Operating Margin (MRQ) 1.06 %
Net Margin (MRQ) 4.37 %
Net Cash Flow Margin (MRQ) 18.66 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 4.63 %
Return On Investment (TTM) 6.02 %
Return On Equity (TTM) 6.98 %
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.